Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma

Sponsor
Azienda Ospedaliera San Giovanni Battista
Study ID
NCT00435955
Phase
PHASE3
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 60 Years
Healthy Volunteers
Not accepted

Interventions

  • High dose chemotherapy with autologous transplantation — PROCEDURE
  • Rituximab — DRUG

Study Details

The purpose of this study is to determine whether an intensified treatment plus Rituximab followed by autologous transplantation is superior to a conventional chemotherapy regimen also supplemented with Rituximab.

Key Dates

Start date
Mar 31, 2000
Status verified
Feb 2007

Study Design

Enrollment
240 participants
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Primary Outcome Measure

Event free survival at three years

Related Studies